BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Myers JS, von Lersner AK, Sang QX. Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues. J Cancer 2016;7:1452-64. [PMID: 27471561 DOI: 10.7150/jca.15860] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Subramanian U, Devarajan B. Identification of dysregulated pathways and key genes in human retinal angiogenesis using microarray metadata. Gene Reports 2022;26:101434. [DOI: 10.1016/j.genrep.2021.101434] [Reference Citation Analysis]
2 Gómez-Cebrián N, Poveda JL, Pineda-Lucena A, Puchades-Carrasco L. Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches. Cancers (Basel) 2022;14:596. [PMID: 35158864 DOI: 10.3390/cancers14030596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yan Y, Yeon SY, Qian C, You S, Yang W. On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances. Int J Mol Sci 2021;22:13537. [PMID: 34948334 DOI: 10.3390/ijms222413537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nagaya N, Rosenfeld J, Lee GT, Kim IY. RNA-seq profile of African American men with a clinically localized prostate cancer. Prostate Int 2021;9:125-31. [PMID: 34692584 DOI: 10.1016/j.prnil.2020.11.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Hardiman G, Savage SJ, Hazard ES, da Silveira WA, Morgan R, Harris A, Jefferson MS, Wilson RC, Caulder S, Ambrose L, Frey L, Wolf B, Gattoni-Celli S, Hughes Halbert C. A Systems Approach to Interrogate Gene Expression Patterns in African American Men Presenting with Clinically Localized Prostate Cancer. Cancers (Basel) 2021;13:5143. [PMID: 34680291 DOI: 10.3390/cancers13205143] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sadeesh N, Scaravilli M, Latonen L. Proteomic Landscape of Prostate Cancer: The View Provided by Quantitative Proteomics, Integrative Analyses, and Protein Interactomes. Cancers (Basel) 2021;13:4829. [PMID: 34638309 DOI: 10.3390/cancers13194829] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Püschel J, Dubrovska A, Gorodetska I. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells. Cancers (Basel) 2021;13:4703. [PMID: 34572930 DOI: 10.3390/cancers13184703] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Scaglia N, Frontini-López YR, Zadra G. Prostate Cancer Progression: as a Matter of Fats. Front Oncol 2021;11:719865. [PMID: 34386430 DOI: 10.3389/fonc.2021.719865] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Ludwig M, Rajvansh R, Drake JM. Emerging Role of Extracellular Vesicles in Prostate Cancer. Endocrinology 2021;162:bqab139. [PMID: 34232289 DOI: 10.1210/endocr/bqab139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Fernández LP, Gómez de Cedrón M, Ramírez de Molina A. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment. Front Oncol 2020;10:577420. [PMID: 33194695 DOI: 10.3389/fonc.2020.577420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
11 O'Sullivan SE, Kaczocha M. FABP5 as a novel molecular target in prostate cancer. Drug Discov Today 2020:S1359-6446(20)30375-5. [PMID: 32966866 DOI: 10.1016/j.drudis.2020.09.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
12 Zhang WL, Wang SS, Jiang YP, Liu Y, Yu XH, Wu JB, Wang K, Pang X, Liao P, Liang XH, Tang YL. Fatty acid synthase contributes to epithelial-mesenchymal transition and invasion of salivary adenoid cystic carcinoma through PRRX1/Wnt/β-catenin pathway. J Cell Mol Med 2020;24:11465-76. [PMID: 32820613 DOI: 10.1111/jcmm.15760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Blomme A, Ford CA, Mui E, Patel R, Ntala C, Jamieson LE, Planque M, McGregor GH, Peixoto P, Hervouet E, Nixon C, Salji M, Gaughan L, Markert E, Repiscak P, Sumpton D, Blanco GR, Lilla S, Kamphorst JJ, Graham D, Faulds K, MacKay GM, Fendt SM, Zanivan S, Leung HY. 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nat Commun 2020;11:2508. [PMID: 32427840 DOI: 10.1038/s41467-020-16126-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
14 Carbonetti G, Wilpshaar T, Kroonen J, Studholme K, Converso C, d'Oelsnitz S, Kaczocha M. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis. Sci Rep 2019;9:18944. [PMID: 31831821 DOI: 10.1038/s41598-019-55418-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
15 Naeem AA, Abdulsamad SA, Rudland PS, Malki MI, Ke Y. Fatty acid-binding protein 5 (FABP5)-related signal transduction pathway in castration-resistant prostate cancer cells: a potential therapeutic target. Precision Clinical Medicine 2019;2:192-6. [DOI: 10.1093/pcmedi/pbz015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Gonthier K, Poluri RTK, Audet-walsh É. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 2019;191:105367. [DOI: 10.1016/j.jsbmb.2019.04.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
17 Al-Jameel W, Gou X, Jin X, Zhang J, Wei Q, Ai J, Li H, Al-Bayati A, Platt-Higgins A, Pettitt A, Rudland PS, Ke Y. Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ. Genes Cancer 2019;10:80-96. [PMID: 31258834 DOI: 10.18632/genesandcancer.192] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
18 Gómez-Cebrián N, Rojas-Benedicto A, Albors-Vaquer A, López-Guerrero JA, Pineda-Lucena A, Puchades-Carrasco L. Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers. Metabolites 2019;9:E48. [PMID: 30857149 DOI: 10.3390/metabo9030048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
19 Nitschke K, Erben P, Waldbillig F, Abdelhadi A, Weis C, Gottschalt M, Wahby S, Nuhn P, Boutros M, Michel MS, von Hardenberg J, Worst TS. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5. World J Urol 2020;38:637-45. [DOI: 10.1007/s00345-019-02651-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
20 Amiri M, Yousefnia S, Seyed Forootan F, Peymani M, Ghaedi K, Nasr Esfahani MH. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers. Gene 2018;676:171-83. [PMID: 30021130 DOI: 10.1016/j.gene.2018.07.035] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 11.3] [Reference Citation Analysis]
21 Guaita-esteruelas S, Gumà J, Masana L, Borràs J. The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5. Molecular and Cellular Endocrinology 2018;462:107-18. [DOI: 10.1016/j.mce.2017.02.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 59] [Article Influence: 11.8] [Reference Citation Analysis]
22 Khan S, Simpson J, Lynch JC, Turay D, Mirshahidi S, Gonda A, Sanchez TW, Casiano CA, Wall NR. Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS One 2017;12:e0183122. [PMID: 28981528 DOI: 10.1371/journal.pone.0183122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
23 Shi Z, Zhou H, Pan B, Lu L, Wei Z, Shi L, Yao X, Kang Y, Feng S. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray. Mol Med Rep 2017;16:7423-31. [PMID: 28944885 DOI: 10.3892/mmr.2017.7577] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
24 Chen L, Zhu Z, Gao W, Jiang Q, Yu J, Fu C. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity. Gene 2017;627:484-90. [DOI: 10.1016/j.gene.2017.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]